	Fosamax Osteonecrosis

FOSAMAX AND JAW OSTEONECROSIS

Patient who received IV bisphosphonates develops jaw osteonecrosis
American Academy of Periodontology
April 11, 2006

Chicago – The patient of a periodontist in private practice in New Orleans developed osteonecrosis of the jaw (ONJ), a condition that can cause severe, often irreversible and debilitating damage to the jaw, following periodontal surgical therapy. Two years prior to surgery, the patient had started receiving IV bisphosphonate therapy, or bone-sparing drugs commonly used in the treatment of osteoporosis and metastatic bone cancer to help decrease associated pain and fractures, following treatment for breast carcinoma. When the patient presented to the periodontist, no reports of ONJ had been reported in the literature. This case report is published in the April issue of the Journal of Periodontology (JOP).

"It is counter-intuitive to believe that bone-sparing drugs such as IV bisphosphonates can have the opposite affect and actually necrotize the jaw bone," said Kristi M. Soileau, DDS, case report author and member of the American Academy of Periodontology (AAP). "While we're not sure exactly why this happens, one possibility is that the drug compromises the vascular supply, which contributes to non-healing or the development of a diseased wound once the bone is exposed such as with extractions or with oral surgery."

"It is important that our colleagues in dentistry and medicine are aware of this potential complication in this large and growing population of patients for whom IV bisphosphonates are being prescribed," explained Kenneth A. Krebs, DMD and AAP president. "A complete dental examination, including a periodontal evaluation, should be performed before a patient begins IV bisphosphonate therapy to identify and address any oral conditions, as recommended with preradiation patients," added Soileau.

The case report did not include information related to patients taking oral bisphosphonates, which are more relevant to osteoporotic concerns.

If you suffer from jaw osteonecrosis (ONJ) or death of the jaw as a result of taking Fosamax you should contact an attorney. Please fill out the form below and your submission will be forwarded to an experienced attorney.

Free Consultation

Title:
First Name:	*
Middle Name:
Last Name:	*
Home Phone:	*
Cell Phone:
Work Phone:
Email Address:
Address:	*
City:	*
State, Zip:	* *
What is the best way to reach you? Please provide the best place, time and method for contacting you.

Alternate Contact Person (not living in same household)

Title:
First Name:
Last Name:
Home Phone:
Cell Phone:
Work Phone:
Address:
City:
State, Zip:
Relationship to Injured:

Was the patient prescribed Fosamax?	Yes No
For what condition was Fosamax prescribed?
When did Fosamax therapy start?	*
When did Fosamax therapy end?	*
Please list name and address of doctor who prescribed Fosamax:
What dental/jaw problems do you have?
What City/State did these occur in? *
Please list name and address of doctor/dentist who you have seen for these problems:

Has any doctor linked your dental/jaw problems to Fosamax?	Yes No
If so, please list the name and address of doctor/dentist:

Case Description*
Please explain exactly what happened, trying to state
as thoroughly as possible who you believe was responsible
and why you believe that person was negligent:

Comments / Additional Information
Is there anything else that would assist us in
understanding the facts of your case?

To Better Serve You:

Please tell us how you found us? If "other" please specify.

Please specify how you found us (if other than above):

If you found us using a search engine,
please tell us which search engine?

Please tell us exactly what terms you typed into the
search engine to find us? (i.e. Personal Injury Lawyers)

I understand that by filling out this free consultation form I am not forming an attorney client relationship. I understand that I may only retain an attorney by entering into a fee agreement and that by submitting this form I am not entering into a fee agreement. I understand that not all submissions may receive a response.
Yes No

I agree that the above does not constitute a request for legal advice. I agree that any information that I will receive in response to the above question is general information and I will not be charged for the response to this e-mail question. I further understand that the law for each state may vary, and therefore, I will not rely upon this information as legal advice. I agree that if this matter requires advice regarding my home state, local counsel may be contacted for referral of this matter. I understand that email is not secure and thus I am not forming a confidential relationship.
Yes No

I have read and agree with the TERMS AND CONDITIONS
Yes No

By Clicking the box below, I agree to submit my case for a free case evaluation:

* = Required Fields



	Fosamax and Osteoporosis

	Fosamax and the FDA

	Fosamax and Bisphosphonates

	Fosamax and ONJ

	Fosamax and Drug Warnings

	Fosamax and Dental Procedures

	Fosamax and Jaw Osteonecrosis

	Fosamax Litigation

	Fosamax and Death of the Jaw

	Fosamax and Merck

	Fosamax Lawsuits

	Fosamax Lawyers

	Fosamax Q & A

Sheff Law Offices, P.C.
The Daniel Webster Suite
10 Tremont Street
Boston, MA 02108
(888) 423 - 4477

If you would like to receive information regarding potential new lawsuits, class actions, lawsuit settlements and large verdicts, please enter your name and email address below, and press "submit".

FOSAMAXOSTEONCROSIS.COM is owned and operated by the Sheff Law Offices, P.C. and is in no way affiliated with Merck & Co., the makers of Fosamax. The purpose of this web site is to provide basic information about Fosamax uses, its side effects, drug litigation, link to ostenecrosis of the jaw, and/or other select legal topics. The FOSAMAXOSTEONECROSIS.COM web site is owned and operated by Sheff Law Offices, P.C., and does not offer legal advice, recommendations, mediation or counseling. For more information please see our legal disclaimer.

Copyright 2009 © Fosamax Osteonecrosis .com All Rights Reserved.